Rive, Benoît

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

Reif, A., Bitter, I., Buyze, J., Cebulla, K., Frey, R., Fu, D.-J., Ito, T., Kambarov, Y., Llorca, P.-M., Oliveira-Maia, A. J., et al. (2023) · New England Journal of Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 222

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Lam, R., Lamy, F.-X., Danchenko, N., Yarlas, A., White, M. K., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 101

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Saragoussi, D., Touya, M., Haro, J. M., Jönsson, B., Knapp, M., Botrel, B., Florea, I., Loft, H., & Rive, B. (2017) · Neuropsychiatric Disease and Treatment

Treatment of Major DepressionMental Health Treatment and Access

Cited by 63

Persistence of and Changes in Neuropsychiatric Symptoms in Alzheimer Disease Over 6 Months

Ryu, S.-H., Katona, C., Rive, B., & Livingston, G. (2005) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 22

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial

Young, A. H., Llorca, P.-M., Fagiolini, A., Falkai, P., Cardoner, N., Nielsen, R. E., Blomqvist, O., Godinov, Y., Rive, B., Diels, J., et al. (2025) · The British Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 9